JP2022522889A5 - - Google Patents
Info
- Publication number
- JP2022522889A5 JP2022522889A5 JP2021552586A JP2021552586A JP2022522889A5 JP 2022522889 A5 JP2022522889 A5 JP 2022522889A5 JP 2021552586 A JP2021552586 A JP 2021552586A JP 2021552586 A JP2021552586 A JP 2021552586A JP 2022522889 A5 JP2022522889 A5 JP 2022522889A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- antibody
- stage
- composition according
- amyloidosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025003299A JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962814252P | 2019-03-05 | 2019-03-05 | |
| US62/814,252 | 2019-03-05 | ||
| US201962942722P | 2019-12-02 | 2019-12-02 | |
| US62/942,722 | 2019-12-02 | ||
| PCT/IB2020/000186 WO2020178638A1 (en) | 2019-03-05 | 2020-03-05 | Methods of treating al amyloidosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003299A Division JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522889A JP2022522889A (ja) | 2022-04-20 |
| JP2022522889A5 true JP2022522889A5 (https=) | 2023-03-13 |
| JP7619953B2 JP7619953B2 (ja) | 2025-01-22 |
Family
ID=70476256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552586A Active JP7619953B2 (ja) | 2019-03-05 | 2020-03-05 | Ａｌアミロイドーシスを処置する方法 |
| JP2025003299A Pending JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003299A Pending JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US11692024B2 (https=) |
| EP (2) | EP4582446A3 (https=) |
| JP (2) | JP7619953B2 (https=) |
| KR (1) | KR20220019656A (https=) |
| CN (1) | CN113811332A (https=) |
| AU (1) | AU2020231081A1 (https=) |
| BR (1) | BR112021017550A2 (https=) |
| CA (1) | CA3132780A1 (https=) |
| CL (1) | CL2021002318A1 (https=) |
| FR (1) | FR3111560B1 (https=) |
| IL (1) | IL286040A (https=) |
| JO (1) | JOP20210245A1 (https=) |
| MA (1) | MA55209A (https=) |
| MX (1) | MX2021010665A (https=) |
| PH (1) | PH12021552135A1 (https=) |
| SG (1) | SG11202109645QA (https=) |
| WO (1) | WO2020178638A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4582446A3 (en) * | 2019-03-05 | 2025-08-13 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
| CA3192069A1 (en) * | 2020-09-14 | 2022-03-17 | Michael Spector | Method of treating amyloidosis |
| TW202332465A (zh) * | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
| IL314229A (en) * | 2022-01-11 | 2024-09-01 | Prothena Biosciences Ltd | Treatment methods for amyloidosis |
| AR132344A1 (es) * | 2023-04-10 | 2025-06-18 | Medimmune Llc | Optimización de los dominios de unión al antígeno cd3 |
| WO2025170969A1 (en) * | 2024-02-06 | 2025-08-14 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
| US7083784B2 (en) | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| AU2005235811B2 (en) | 2004-02-06 | 2011-11-03 | Morphosys Ag | Anti-CD38 human antibodies and uses therefor |
| JP5225069B2 (ja) | 2005-03-23 | 2013-07-03 | ゲンマブ エー／エス | 多発性骨髄腫の治療のためのｃｄ３８に対する抗体 |
| DK2237803T3 (en) | 2007-12-28 | 2015-10-05 | Prothena Biosciences Ltd | Treatment and prophylaxis of amyloidosis |
| SMT202000031T1 (it) | 2010-06-09 | 2020-03-13 | Genmab As | Anticorpi contro cd38 umano |
| CN107233569B (zh) | 2011-10-25 | 2021-08-31 | 普罗西纳生物科学有限公司 | 抗体制剂和方法 |
| CN108771655A (zh) | 2011-10-28 | 2018-11-09 | 诚信生物公司 | 含有氨基酸的蛋白质制剂 |
| US10213506B2 (en) | 2014-08-26 | 2019-02-26 | University Of Tennessee Research Foundation | Targeting immunotherapy for amyloidosis |
| EA201792546A1 (ru) | 2015-05-20 | 2018-04-30 | Янссен Байотек, Инк. | Антитела к cd38 для лечения амилоидоза легких цепей и прочих cd38-положительных гематологических злокачественных опухолей |
| CA3004152C (en) | 2015-11-03 | 2024-04-16 | Janssen Biotech, Inc. | Subcutaneous formulations of anti-cd38 antibodies and their uses |
| ES2914781T3 (es) | 2016-06-30 | 2022-06-16 | Prothena Biosciences Ltd | Composiciones para el tratamiento de la amiloidosis |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| US12018069B2 (en) | 2018-06-28 | 2024-06-25 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for imaging amyloid deposits |
| JP2022520572A (ja) | 2019-02-12 | 2022-03-31 | プロシーナ バイオサイエンシーズ リミテッド | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |
| EP4582446A3 (en) * | 2019-03-05 | 2025-08-13 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
| TW202332465A (zh) | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
-
2020
- 2020-03-05 EP EP25163966.2A patent/EP4582446A3/en active Pending
- 2020-03-05 SG SG11202109645Q patent/SG11202109645QA/en unknown
- 2020-03-05 WO PCT/IB2020/000186 patent/WO2020178638A1/en not_active Ceased
- 2020-03-05 JP JP2021552586A patent/JP7619953B2/ja active Active
- 2020-03-05 CA CA3132780A patent/CA3132780A1/en active Pending
- 2020-03-05 MA MA055209A patent/MA55209A/fr unknown
- 2020-03-05 MX MX2021010665A patent/MX2021010665A/es unknown
- 2020-03-05 PH PH1/2021/552135A patent/PH12021552135A1/en unknown
- 2020-03-05 CN CN202080033593.5A patent/CN113811332A/zh active Pending
- 2020-03-05 BR BR112021017550A patent/BR112021017550A2/pt unknown
- 2020-03-05 US US16/810,319 patent/US11692024B2/en active Active
- 2020-03-05 KR KR1020217031814A patent/KR20220019656A/ko active Pending
- 2020-03-05 EP EP20722638.2A patent/EP3934689B1/en active Active
- 2020-03-05 AU AU2020231081A patent/AU2020231081A1/en active Pending
-
2021
- 2021-06-16 FR FR2106376A patent/FR3111560B1/fr active Active
- 2021-09-01 IL IL286040A patent/IL286040A/en unknown
- 2021-09-03 CL CL2021002318A patent/CL2021002318A1/es unknown
- 2021-09-05 JO JOP/2021/0245A patent/JOP20210245A1/ar unknown
-
2023
- 2023-05-08 US US18/313,792 patent/US12240894B2/en active Active
-
2025
- 2025-01-09 JP JP2025003299A patent/JP2025063135A/ja active Pending
- 2025-03-03 US US19/068,630 patent/US20250188159A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522889A5 (https=) | ||
| US20230159647A1 (en) | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor | |
| JP7164530B2 (ja) | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 | |
| MX2007000748A (es) | Metodos para tratar el sindrome de sjogren. | |
| US20240141051A1 (en) | Methods for treating hand and foot dermatitis by administering an il-4r antagonist | |
| JP2022500382A5 (https=) | ||
| JP2006501283A (ja) | ＬＦＡ−１αサブユニット抗体と利用方法 | |
| US20180327505A1 (en) | Method for treating multiple sclerosis | |
| DE202021004005U1 (de) | Ofatumumab zur Behandlung von MS unter Beibehaltung des IgG im Serum | |
| JP2024505923A5 (https=) | ||
| US20240350626A1 (en) | Methods for treating eosinophilic gastroenteritis by administering an il-4r antagonist | |
| JP2022520572A5 (https=) | ||
| US7396530B2 (en) | Method of treating granuloma annulare or sarcoid | |
| CN113993543B (zh) | 使用抗cd38抗体的组合疗法 | |
| US20020110558A1 (en) | Use of CD25 binding molecules in the treatment of rheumatoid arthritis or skin diseases | |
| AU2022228198B9 (en) | Method for treating multiple sclerosis | |
| US20260070995A1 (en) | Methods for treating bullous pemphigoid by administering an il-4r antagonist | |
| KR20260049559A (ko) | 이중특이적 항-PSMA x 항-CD28 항체를 이용한 투명 세포 신세포 암종의 치료 방법 | |
| Stevenson | The prospects for treating cancer with antibody | |
| WO2025106736A2 (en) | Combination of pd-1 inhibitors and lag-3 inhibitors for enhanced efficacy in treating lung cancer | |
| CN118021955A (zh) | 用于治疗il-17a介导的疾病或病症的方法和组合物 | |
| HK40022146A (en) | Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor | |
| KR20260056325A (ko) | Il-4r 억제제를 투여하여 아토피성 피부염을 치료하는 방법 | |
| HK1216898B (en) | Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor |